Cargando…

Effect of regular intravenous immunoglobulin therapy on prognosis of severe pneumonia in patients with COVID-19

Detalles Bibliográficos
Autores principales:	Xie, Yun, Cao, Song, Dong, Hui, Li, Qingyun, Chen, Erzhen, Zhang, Wenkai, Yang, Luyu, Fu, Shouzhi, Wang, Ruilan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The British Infection Association. Published by Elsevier Ltd. 2020
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7151471/ https://www.ncbi.nlm.nih.gov/pubmed/32283154 http://dx.doi.org/10.1016/j.jinf.2020.03.044

Ejemplares similares

Intravenous Immunoglobulin and Favipiravir treatment for A Kidney Transplant Patient with Severe Covid-19 Pneumonia
por: Tatar, Erhan, et al.
Publicado: (2020)

Intravenous immunoglobulins for treatment of severe COVID-19-related acute encephalopathy
por: Huo, Shufan, et al.
Publicado: (2022)

Intravenous Immunoglobulin for Severe Protracted Pediatric Guillain–Barre Syndrome: Is Single Dose Adequate?
por: Madaan, Priyanka, et al.
Publicado: (2019)

Immune-Checkpoint-Inhibitor-Induced Severe Autoimmune Encephalitis Treated by Steroid and Intravenous Immunoglobulin
por: Kim, Ahwon, et al.
Publicado: (2019)

Prioritization of Evidence-Based Indications for Intravenous Immunoglobulin
por: Orange, Jordan S., et al.
Publicado: (2013)

Pulmonary Embolism Secondary to Intravenous Immunoglobulin in a Child with Leukemia
por: Seren Oğuz, Işıl, et al.
Publicado: (2021)

Effect of high-dose intravenous vitamin C on prognosis in patients with SARS-CoV-2 pneumonia
por: Yildirim, Fatma, et al.
Publicado: (2022)

Effect of high-dose intravenous vitamin C on prognosis in patients with SARS-CoV-2 pneumonia
por: Yildirim, Fatma, et al.
Publicado: (2022)

Aseptic meningitis following intravenous immunoglobulin therapy of common variable immunodeficiency
por: Kaarthigeyan, K., et al.
Publicado: (2011)

Aseptic meningitis following intravenous immunoglobulin therapy of common variable immunodeficiency
por: Bhatt, Girish Chandra, et al.
Publicado: (2012)

Susac Syndrome With Good Response to Intravenous Immunoglobulin: A Case Report
por: Kim, Seokhyun, et al.
Publicado: (2023)

Cerebral Venous Thrombosis after Intravenous Immunoglobulin Therapy in Immune Thrombocytopenic Purpura
por: Al-Mendalawi, Mahmood Dhahir
Publicado: (2018)

Successful intravenous immunoglobulin treatment in severe COVID-19 pneumonia
por: Lanza, Maurizia, et al.
Publicado: (2020)

Intravenous Immunoglobulin Therapy for Persistent Pemphigoid Gestationis with Steroid Induced Iatrogenic Cushing's Syndrome
por: Ko, Bum Joon, et al.
Publicado: (2014)

Intravenous immunoglobulins: A therapeutic alternative to consider in kidney transplant patients with COVID-19()
por: Sánchez Cadena, Abraham David, et al.
Publicado: (2021)

Acute syndrome of apoptotic pan-epidermolysis successfully treated with intravenous immunoglobulin and steroid combination
por: Şentürk, Nilgun, et al.
Publicado: (2022)

Intravenous immunoglobulin: A potential treatment for the post-acute sequelae of SARS-Cov-2 infection?
por: Reznik, Sandra E., et al.
Publicado: (2022)

Regular dental check-ups could be of benefit for patients receiving intravenous bisphosphonates. Regarding ‘risks and benefits of bisphosphonates’
por: Kyrgidis, A, et al.
Publicado: (2009)

Anti A/B Antibody Titer Rebound: Are we Making it Worse? Be Aware of Your Intravenous Immunoglobulin
por: Kher, A., et al.
Publicado: (2018)

May early intervention with intravenous immunoglobulin pose a potentially successful treatment for Ebola virus infection?
por: Ge, Ying, et al.
Publicado: (2014)

Identification of risk factors for mortality associated with COVID-19
por: Yu, Yuetian, et al.
Publicado: (2020)

Non-Eczematous Vesiculobullous Skin Eruption after Stevens-Johnson Syndrome: Developed without Intravenous Immunoglobulin Therapy
por: Kim, Jin A, et al.
Publicado: (2014)

Shift from intravenous or 16% subcutaneous replacement therapy to 20% subcutaneous immunoglobulin in patients with primary antibody deficiencies
por: Canessa, Clementina, et al.
Publicado: (2016)

High-dose intravenous immunoglobulin therapy for novel coronavirus disease 2019: a brief report of two cases
por: Erdogan, Cem, et al.
Publicado: (2020)

Age and Stroke Severity: Hazards for Intravenous Thrombolysis?
por: Long, Chuyan, et al.
Publicado: (2015)

Toxic epidermal necrolysis in an 8-year-old girl successfully treated with cyclosporin A, intravenous immunoglobulin and plasma exchange
por: Zielińska, Marzena, et al.
Publicado: (2018)

Effect of intravenous immunoglobulin therapy on the prognosis of patients with severe fever with thrombocytopenia syndrome and neurological complications
por: Liu, Yun, et al.
Publicado: (2023)

High-Dose Intravenous Immunoglobulins in the Treatment of Severe Acute Viral Pneumonia: The Known Mechanisms and Clinical Effects
por: Liu, Xiaosheng, et al.
Publicado: (2020)

Treatment of West Nile virus encephalitis with intravenous immunoglobulin.
por: Shimoni, Z, et al.
Publicado: (2001)

Effect of Combined Intravenous Immunoglobulin and Mycophenolate Mofetil in a Pediatric Patient With Highly Relapsing Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease
por: Kim, Ki Hoon, et al.
Publicado: (2022)

Successful Use of Intravenous Immunoglobulins in an Obinutuzumab-related Acute Thrombocytopenia
por: Haage, Tobias R., et al.
Publicado: (2022)

Correlation between clinical course and radiographic development on CT scan in patients with COVID-19
por: Xie, Yun, et al.
Publicado: (2021)

Severe skin extravasation injury following intravenous injection of potassium chloride
por: Richa, Freda C., et al.
Publicado: (2019)

Intravenous immunoglobulins in infantile dyshidrosiform bullous pemphigoid refractory to steroids and dapsone
por: Viglizzo, Gianmaria, et al.
Publicado: (2022)

Severe Pneumonia and Human Bocavirus in Adult
por: Kupfer, Bernd, et al.
Publicado: (2006)

Outcome of hospitalized patients with COVID-19 pneumonia treated with high-dose immunoglobulin therapy in a prospective case series
por: Reynaga, Esteban, et al.
Publicado: (2021)

Intravenous Immunoglobulin-Associated Severe Hemolytic Anemia
por: KC, Ojbindra, et al.
Publicado: (2023)

Intravenous immunoglobulin for acute exacerbation of fibrotic idiopathic interstitial pneumonias
por: Higo, Hisao, et al.
Publicado: (2022)

Covid-19: high rates of severity and death in elderly and patients with chronic diseases reinforces the importance of regular physical activity
por: Speretta, Guilherme F., et al.
Publicado: (2020)

Maternal immunoglobulin treatment can reduce severity of fetal acetylcholine receptor antibody-associated disorders (FARAD)
por: Wassenberg, Matthias, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_pvvosdcf62g5gbshg8i7h419cs